Forward Industries’ Nov. 10 update puts the Solana treasury company’s shares at a 29.7% discount to net assets using common shares alone.
Counting all the potential shares in the same disclosure, that discount shrinks to 2.4%. The difference is who could eventually share in the assets.
The share count is key almost as much as the treasury for investors comparing Nasdaq-listed FWDI with buying Solana directly.
The capitalization update uses a $5.53 share price and $600.2 million of net asset value (NAV). Forward’s accompanying 8-K says the figures are preliminary, unaudited, and incomplete.
Three discounts for three share counts
Dividing the same net assets among more potential shares produces three distinct comparisons:
| November 9 basis | Share count | NAV per share | Calculated discount |
|---|---|---|---|
| Common shares | 76,288,215 | $7.87 | 29.7% |
| In-the-money fully diluted | 90,300,322 | $6.65 | 16.8% |
| Fully diluted | 105,933,854 | $5.67 | 2.4% |
Each discount is calculated as 1 minus the share price divided by NAV per share, using unrounded values.
The middle count already recognizes substantial claims beyond issued common stock: 12.27 million vested warrants with a displayed exercise price of $0.00, 689,010 options and 1.05 million unvested restricted stock units. It includes unvested options as well as vested ones.
Using the displayed prices for the two in-the-money option categories would add about $3.4 million if both groups vested and exercised for cash. With price, share count, and everything else fixed, that lifts the calculated discount to about 17.3%.
The largest addition between the middle and broadest counts is 13.38 million advisor and lead-investor warrants with a one-cent exercise price. Other additions include out-of-the-money options and warrants, plus 875,324 unvested performance stock units.
The accompanying prospectus to Forward’s Nov. 9 filing describes three equal tranches requiring closing prices at 150%, 200% and 250% of the placement purchase price for 20 of 30 trading days after the relevant registration effectiveness.
Against the disclosed $18.50 purchase price, those trigger levels work out to $27.75, $37 and $46.25, subject to applicable adjustments.
If all 13.38 million warrants were exercised for cash at one cent, Forward would receive only about $134,000. The advisor warrant form and lead-investor warrant form also permit cashless exercise.
What adds the final 15.63m potential shares?
Most of the broad-count addition comes from sponsor warrants. The levels below are contractual trigger arithmetic, not a price forecast or proof of present exercisability.
The remaining potential shares combine out-of-the-money instruments and unvested performance awards. Their inclusion does not mean issuance has occurred.
Sponsor warrants make up most of the additional shares in the broadest count; their penny exercise price is separate from their activation hurdles.
All counts are dated and preliminary. Potential shares are not a forecast of issuance. Historical sponsor-trigger satisfaction is untested. Thresholds are subject to adjustments; the June award note does not establish every November grant’s schedule.
Forward’s June-quarter filing describes management restricted stock units vesting over four years with service conditions, while performance units require both service and company performance measures.
The broadest count captures these potential ownership claims, but does not establish when, or whether, all will become issued shares.
A treasury metric is not a Solana withdrawal right
Forward’s reported NAV combines $755.9 million of SOL and equivalents, $26.6 million of other digital assets and $5.25 million of cash and marketable securities, less $187.5 million of institutional debt.
The 8.73 million Solana-equivalent balance includes fwdSOL and pledged SOL and excludes borrowed SOL.
That debt is already deducted in the NAV calculation, and Forward warns that declines in pledged SOL could require additional collateral or repayment.
The company’s common-share terms provide no redemption provisions, so its reported 0.0824 SOL per fully diluted share is a treasury exposure metric. A discount alone supplies no contractual route to collect the difference.
November’s amendment added Barclays to the existing up-to-$4 billion equity sales program. The prospectus reports only 529,257 shares sold for about $12.1 million gross through Nov. 6.
Token ownership is the exposure for direct SOL buyers, while the judgment also concerns management’s use of assets and financing, and which contingent claims to include for FWDI buyers.
The middle measure leaves a meaningful dated discount, while the broadest leaves little cushion.
